Advertisement

Meeting Coverage

AHA Scientific Sessions: Schedule at a Glance

“One World. Together for Science.” #AHA21 Join the American Heart Association Scientific Sessions 2021 virtual platform for the global cardiovascular event of the year. The virtual platform let’s you reconnect...

Read More

AAO 2021 Annual Meeting Kicks Off

The world’s largest gathering of ophthalmologists kicking off tomorrow. The American Academy of Ophthalmology® will hold its 2021 Annual Meeting November 12-15, 2021, in New Orleans, with on-demand sessions available. The...

Read More

AAO 2021 Meeting Coverage: Schedule Overview

The American Academy of Ophthalmology has posted an overview of this year’s meeting schedule: Source: American Academy of Ophthalmology. To download the PDF, please visit www.aao.org or click here.

Read More

Vaccines Required to Attend AAO 2021

For this year’s American Academy of Ophthalmology annual meeting, the AAO organization has created the following health and safety requirements as they are committed to the health and well-being of meeting attendees,...

Read More

Age & MS Status Independently Impact HRQOL

Data indicate that individuals with MS experience decreased HRQOL compared with the general population, but research is lacking on changes in MS as a function of aging. To investigate this relationship, researchers examined...

Read More

Conditioned Pain Modulation Intact in Dry Eye

To assess the role of conditioned pain modulation (CPM), a measure of inhibitory pain pathways, in dry eye management (DE), researchers conducted a cross-sectional study of 268 patients from October 2017 to August 2018. They...

Read More

Antisense Therapies to be featured at the AHA 2021

The upcoming presentations of clinical and non-clinical data from its cardiovascular pipeline, including several of its investigational antisense medicines for cardiovascular disease, at the American Heart Association (AHA)...

Read More

Teprotumumab for Long-Standing, Active TED

While phase II and III trials indicate that teprotumumab therapy can significantly reduce proptosis and Clinical Activity Score (CAS) in patients with recent-onset (< 8 months), untreated TED (except for steroid therapy >...

Read More

Recalcitrant TED Responsive to Teprotumumab

New research presented at the American Society of Ophthalmic Plastic & Reconstructive Surgery’s fall symposium highlighted the benefits of Tepezza (teprotumumab) for patients with thyroid eye and Graves disease....

Read More

What causes NMOSD? Clues from a Canadian Cohort

Disease risk factors and the underlying etiology for neuromyelitis optica spectrum disorder (NMOSD) are not known. Using controls and the validated questionnaire from the Environmental Risk Factors in MS Study (EnvIMS) study [1]...

Read More

ACR 2021 Features Sessions

Keynote Lecture: The Covidization of Rheumatology: What Will or Won’t Change Beyond the COVID-19 Pandemic Track: COVID-19 November 5, 2:40 – 3:20 PM ET Speaker: Seema Yasmin, MD During this keynote session, Dr. Yasmin,...

Read More

ASN Kidney Week Learning Pathways

The following learning pathways will help attendees locate sessions in their area of interest: Acute Kidney Injury Bone and Mineral Metabolism Cell and Transport Physiology Chronic Kidney Disease Development and Pediatrics...

Read More

ACR Convergence 2021 Accepted Abstracts

Accepted abstracts will be published in an online supplement of the Arthritis & Rheumatology journal. Accepted and late-breaking abstracts are also available on the ACR Convergence Meeting Abstracts website. Check out...

Read More
Advertisement